An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

2020 Science Translational Medicine 1,132 citations

Abstract

A ribonucleoside analog inhibits SARS-CoV-2 in human airway epithelial cell cultures and SARS-CoV and MERS-CoV in mice.

Keywords

VirologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OutbreakCoronavirusVero cellBiology2019-20 coronavirus outbreakPandemicBioavailabilityPneumoniaMicrobiologyVirusMedicinePharmacologyDiseaseInfectious disease (medical specialty)Pathology

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
12
Issue
541
Citations
1132
Access
Closed

External Links

Citation Metrics

1132
OpenAlex

Cite This

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science Translational Medicine , 12 (541) . https://doi.org/10.1126/scitranslmed.abb5883

Identifiers

DOI
10.1126/scitranslmed.abb5883